Impact of heterogeneity in the care of patients with rheumatoid arthritis or psoriatic arthritis on the effectiveness of two types of care: Interaction analysis of data from the StaerkeR study.

Impact of heterogeneity in the care of patients with rheumatoid arthritis or psoriatic arthritis on the effectiveness of two types of care: Interaction analysis of data from the StaerkeR study. - StaerkeR-heterogeneity

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029601

Enrollment

601

Registered

2022-09-05

Start date

2022-06-10

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M05.8 M06.9 M07.3

Interventions

Group 1: Standard care of patients by the rheumatologist Group 2: Specialized rheumatological assistant-guided care in collaboration with the rheumatologist

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with a stable course of chronic polyarthritis or psoriatic arthritis (polyarticular form)

Exclusion criteria

Exclusion criteria: limited legal capacity, insufficient language skills, highly active or life-threatening illness

Design outcomes

Primary

Measure	Time frame
1. disease activity measured by DAS28 after one year 2. quality of life measured by EQ 5D-5L after one year	—

Secondary

Measure	Time frame
Patient satisfaction, functional capacity	—

Countries

Germany

Contacts

Public ContactAnna Mai

Ruhr-Universität Bochum, Abteilung für medizinische Informatik, Biometrie und Epidemiologie

mai@amib.rub.de+49 (0)234-32-27918

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026